[Federal Register Volume 76, Number 193 (Wednesday, October 5, 2011)]
[Page 61719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-25733]



National Institutes of Health

Notice of a meeting of a working group of the NIH Blue Ribbon 

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories at Boston University 
Medical Center.
    The meeting will be held Wednesday, November 2, 2011, at the Hyatt 
Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814 from 
approximately 8:30 a.m. to 4:30 p.m.
    This meeting is the fourth in a series of public meetings to review 
and discuss the ongoing supplementary risk assessment study being 
conducted for the Boston University NEIDL. The National Research 
Council Committee on Technical Input will participate in this 
discussion and provide its views.
    Public comment will begin at approximately 4 p.m. In the event that 
time does not allow for all those interested to present oral comments, 
anyone may file written comments by sending them to the address below. 
Comments should include the name, address, telephone number and when 
applicable, the business or professional affiliation of the commenter.
    The meeting will be open to the public, with attendance limited to 
space available. There will be a live webcast of the meeting which can 
be accessed at http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    A draft agenda and slides for the meeting may be obtained by 
connecting to http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For 
additional information concerning this meeting, contact Ms. Kelly 
Fennington, Senior Health Policy Analyst, Office of Biotechnology 
Activities, Office of Science Policy, Office of the Director, National 
Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 
20892-7985; telephone 301-496-9838; e-mail [email protected].

    Dated: September 27, 2011.
Amy P. Patterson,
Director, Office of Science Policy, National Institutes of Health.
[FR Doc. 2011-25733 Filed 10-4-11; 8:45 am]